Intrinsic value of Kiniksa Pharmaceuticals, Ltd. (KNSA)
Live fair value data for Kiniksa Pharmaceuticals, Ltd. (KNSA) is currently unavailable. Please check again shortly.
Current Price: $281.00
Valuation: Overvalued
Confidence: 6.5/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Kiniksa Pharmaceuticals, Ltd. (KNSA) undervalued or overvalued?
Based on the current model output, Kiniksa Pharmaceuticals, Ltd. appears to be overvalued with a downside of 21.00%.
Fair value vs market price — Kiniksa Pharmaceuticals, Ltd. (KNSA)
Unlock premium access to view the live fair value comparison against current market price for KNSA.
Frequently Asked Questions - KNSA
How is KNSA intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for KNSA.
Is KNSA undervalued or overvalued right now?
KNSA is currently shown as overvalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for KNSA: open their intrinsic value pages.